Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|April 24, 2015
Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) InfluenzaZhongshan Cheng, Jie Zhou, Kelvin Kai-Wang To, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 25, 2020
Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatmentsQianda Zou, Shufa Zheng, Xiaochen Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 17, 2020
Hock-a-loogie saliva as a diagnostic specimen for SARS-CoV-2 by a PCR-based assay: A diagnostic validity studyJian Fan, Fei Yu, Xiang Wang, et al.
The Journal of Infectious Diseases|August 13, 2013
Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological studyShigui Yang, Yu Chen, Dawei Cui, et al.
The Journal of Infectious Diseases|June 1, 2020
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control StudyShaorui Hao, Jiangshan Lian, Yingfeng Lu, et al.
Frontiers in Immunology|September 7, 2021
Cytokine Signature Associated With Disease Severity in COVID-19Jing Guo, Shuting Wang, He Xia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virusLiang Yu, Zhaoming Wang, Yu Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2022
Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID-19 and its Association with Microbiota in the GutYifei Shen, Fei Yu, Dan Zhang, et al.
Gut Microbes|June 12, 2023
Dynamic associations between the respiratory tract and gut antibiotic resistome of patients with COVID-19 and its prediction power for disease severityYifei Shen, Wenxin Qu, Fei Yu, et al.
Signal Transduction and Targeted Therapy|September 3, 2024
Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 studyZhiyong Zeng, Apeng Yang, Jingke Yang, et al.
Pageof 10